DONA Pharmacy has a new General Manager. With over 27 years of experience in retail, FMCG and pharma, in operational and management positions, Aura Rădulescu has taken over the leadership of one of the largest entrepreneurial businesses in the local pharmaceutical retail. With a tradition of over 30 years, DONA has a network of over 330 pharmacies distributed throughout the country and a team of over 1,700 healthcare specialists.

“We are delighted to complete the top management team with a high-level executive. Ms. Rădulescu has both the necessary experience, values ​​and leadership skills to further DONA’s mission and to contribute to the sustainable development of the company in a dynamic economic context. I am convinced that together we will achieve important achievements, with a visible positive effect on patients,” said Eugen Banciu, owner of the DONA Group.

“I am honored to join one of the most respected companies in the Romanian pharmaceutical retail. DONA Pharmacy is a network with strong roots, a clear mission and a truly remarkable team. I find myself in DONA’s values ​​and vision. The compatibility was so natural that it allowed me to quickly focus on future strategic directions. I am with the team in the mission to support patients with professionalism and real solutions. Caring for people, concern for the quality of life and the desire to contribute to a healthier life for each patient are part of our DNA. We also remain a trusted partner for partners and collaborators. We are a financially stable and sustainable entrepreneurial company, with ambitious expansion plans and constant investments in technology and infrastructure”, said Aura Rădulescu, General Manager of the Retail Division – DONA Pharmacy.

In 2024, the DONA Group reported a consolidated turnover of over 3 billion lei, obtained from the drug distribution company and retail – DONA pharmacies. For 2025, the group’s turnover target is 3.6 billion lei, up 20% compared to last year, above the market average, aiming to consolidate its position in the top pharmacy networks. A new drug warehouse, network expansion through the acquisition of new pharmacy licenses and the online store are the main investment directions for 2025.